|
End-of-day quote
Shenzhen S.E.
16/09/2026
|
5-day change | 1st Jan Change | ||
| 3.770 CNY | +0.53% |
|
-5.99% | -14.90% |
| 08-26 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Fuan Pharmaceutical Subsidiary Gets China Approval for Three Injectable Drugs | MT |
| Market Cap | 4.49B 670M 583M 552M 499M 935M 64.24B 945M 6.59B 2.54B 32.6B 2.52B 2.46B 105B | P/E 2024 |
18.6x | P/E 2025 | 73.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.25B 634M 552M 523M 473M 885M 60.86B 895M 6.24B 2.41B 30.88B 2.38B 2.33B 99.13B | EV / Sales 2024 |
2.15x | EV / Sales 2025 | 2.9x |
| Free-Float |
68.44% | Yield 2024 |
1.12% | Yield 2025 | 1.58% |
| 1 day | +0.53% | ||
| 1 week | -5.99% | ||
| Current month | -4.80% | ||
| 1 month | -5.75% | ||
| 3 months | +3.57% | ||
| 6 months | -11.71% | ||
| Current year | -14.90% |
| 1 week | 3.71 |  | 3.95 |
| 1 month | 3.71 | | 4.2 |
| Current year | 3.24 | | 4.75 |
| 1 year | 3.24 | | 5 |
| 3 years | 2.92 | | 5.68 |
| 5 years | 2.92 | | 5.68 |
| 10 years | 2.87 | | 11.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 42 | 04/12/2023 |
Xue Song Yu
DFI | Director of Finance/CFO | 57 | 19/09/2009 |
Qin Tang
SEC | Corporate Secretary | 57 | 19/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Tian Xiang Wang
CHM | Chairman | 70 | 19/09/2009 |
Qin Tang
BRD | Director/Board Member | 57 | 19/09/2009 |
Xue Song Yu
BRD | Director/Board Member | 57 | 21/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/01/20 | Sell | Director | 3,000,000 | 0.3361% | ||
| 02/01/20 | Sell | Executive/Senior Manager | 30,300 | 0.0034% | ||
| 02/01/20 | Sell | Chief Financial Officer | 42,200 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | -5.99% | -17.32% | -11.92% | 664M | |
| +1.01% | -1.72% | +15.70% | +61.20% | 45.9B | |
| -4.55% | -7.58% | +28.20% | +96.63% | 38.7B | |
| +0.77% | -3.32% | +6.81% | +71.61% | 11.43B | |
| +0.52% | -1.88% | -12.29% | +9.92% | 11.38B | |
| +0.96% | +0.96% | +20.97% | +148.82% | 9.09B | |
| -0.47% | +0.16% | +24.26% | +36.96% | 7.3B | |
| +1.61% | -2.61% | +14.79% | +181.38% | 6.98B | |
| -1.00% | -3.90% | +34.92% | -20.68% | 7.13B | |
| +0.61% | -4.18% | -43.92% | +5.23% | 4.89B | |
| Average | -0.00% | -2.01% | +7.21% | +57.91% | 14.34B | |
| Weighted average by Cap. | -0.71% | -2.56% | +15.64% | +71.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.39B 357M 311M 294M 266M 498M 34.25B 504M 3.51B 1.35B 17.38B 1.34B 1.31B 55.79B | 1.74B 260M 226M 214M 194M 362M 24.9B 366M 2.55B 985M 12.63B 975M 953M 40.56B |
| Net income | 280M 41.78M 36.36M 34.44M 31.16M 58.31M 4.01B 58.96M 411M 159M 2.03B 157M 153M 6.53B | 77M 11.5M 10.01M 9.48M 8.57M 16.04M 1.1B 16.22M 113M 43.61M 560M 43.18M 42.22M 1.8B |
| Net Debt | -171M -25.46M -22.16M -20.99M -18.99M -35.54M -2.44B -35.93M -251M -96.6M -1.24B -95.63M -93.51M -3.98B | -236M -35.27M -30.7M -29.07M -26.31M -49.23M -3.38B -49.78M -347M -134M -1.72B -132M -130M -5.51B |
Employees
2,988
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | CN¥3.770 | +0.53% | 8,141,453 |
| 15/09/26 | CN¥3.750 | -2.85% | 12,394,800 |
| 14/09/26 | CN¥3.860 | +1.31% | 9,107,100 |
| 11/09/26 | CN¥3.810 | -1.80% | 11,814,300 |
| 10/09/26 | CN¥3.880 | -1.77% | 10,808,397 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300194 Stock
Select your edition
All financial news and data tailored to specific country editions
